Photo credit: David Bell/Photo Features
For infertile couples, the expense, duration and low success rates of assisted reproduction can make the process a physical and emotional ordeal.
Reza Nosrati, a postdoctoral researcher at Queen’s University aims to change that. Using microfluidics and advanced microscopy, he and his colleagues are developing simple but functional technologies for analysing and selecting sperm, and ultimately improving fertilization rates.
Much of his work has focused on male infertility. As a PhD candidate working under microfluidics expert Professor David Sinton at University of Toronto, one of his earliest projects was to design a simple, easy-to-use microfluidic device that would select sperm by “racing” the cells in microchannels. Winners of this race, when examined, showed 80% higher DNA integrity, making them potentially more successful in commercialized reproduction.
This research, which is now being commercialized, led to a subsequent project to characterize how sperm swim within a micrometre of surfaces. It was a significant challenge to capture their motion, he says, because sperm are very small and swim very fast.
In collaboration with a U of T expert in fluorescence microscopy, Professor Christopher Yip, he made an intriguing discovery: when moving close to the surface, human sperm adapt their swimming style from a 3D “corkscrew” motion to a more streamlined 2D “slither” movement that enables them to swim faster. This may be important to successful fertilization, says Nosrati. This was a major breakthrough in understanding sperm movement, and targeting slither swimmers has the potential to improve sperm selection for assisted reproduction.
His subsequent work focused on paper-based microfluidics to identify concentration of sperm, and their motility – how many of them move successfully from point A to B? The device works like a pH strip, used for testing acidity or alkalinity: reagent-coated sections on the paper strip react to a droplet of semen, changing color according to sperm concentration and motility. The latter is an important indicator of the sperm’s success at fertilization, and Dr. Nosrati’s test is the first to quantify that attribute.
Their long-term plan is to pair the device with a cell-phone application that could analyse and track semen quality day to day, enabling individuals to test themselves. “Family doctors could also use it as a first-step diagnostic,” he says. “There’s a lot of embarrassment and anxiety around this, and there aren’t any comprehensive products on the market.”
A related microfluidics device developed with Toronto colleague Dr. Max Gong, aims to diagnose overall sperm health, an important factor in fertilization success, using just a drop of semen. Current gold-standard clinical testing requires access to flow cytometry, an expensive technology that many fertility clinics do not have access to. “We came up with the idea of breaking up the sperm cells to get the DNA out, and then separating healthy and damaged DNA using an electric field.” This low-cost, paper-based approach showed 100% agreement with respect to clinical decision as compared with the flow cytometry-based assay.
While challenges remain – the device requires fluorescent microscopy and a power source – this approach shows potential as an affordable, self-administered alternative to current clinical testing.
Ground-breaking and commercially promising, Dr. Nosrati’s work has generated more than 40 papers, more than a dozen of them in leading scientific journals, as well as global media interest. More recently he was recognized with the Douglas R. Colton Medal for Research Excellence from CMC Microsystems – an honour also presented to his doctoral supervisor, Dr. Sinton, a decade earlier.
But successful research, he is quick to point out, doesn’t just depend on good ideas – it needs the right tools and labs to give those ideas a physical form. Access to prototyping labs and services and R&D tools in optics, microfluidics and microelectronics, and links with industry, all provided through CMC, helped him realize his ideas. “The use of fabrication facilities was key to my success. There are many Canadian researchers who need to fab those very tiny and delicate micro/nanofluidic devices, and the labs are critical in helping us do that.”
Now a Natural Sciences and Engineering Research Council (NSERC) Postdoctoral Fellow in Dr. Carlos Escobedo’s group in the Department of Chemical Engineering at Queen’s University, Dr. Nosrati is developing microsystems for cellular research. His current work includes a collaboration with Dr. Madhuri Koti’s group at Queen’s Cancer Research Institute to develop the cellular microenvironment of the fallopian tube on a microfluidic chip, enabling him to study the interaction of sperm with the wavelike movements of the cilia, tiny hair-like structures that help to move the egg through the fallopian tube. “Realtime observation of this interaction has not been possible to date, so it’s challenging, but may cause a paradigm shift in infertility treatment.”